GL261

  • 1.00 Dollar US$
  • Published date: September 30, 2026
    • Shirley, New York, United States
GL261
GL261

Established as in vitro growing cell culture in the mid 1990s from the Gl261 tumor which was induced in 1939 by intracranial injection of 3-methylcholanthrene into C57BL/6 mice and subsequently maintained by serial transplantation in syngeneic mouse strain

https://www.creative-bioarray.com/GL261-CSC-C9184W-item-42117.htm

Result 0 votes
Hannah Cole
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • B9

    B9

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cells are a subclone derived from B13.29 (first described as clone 9.9) by fusion of BALB/c spleen cells with SP2/0-AG14 myeloma cells; this hybridoma is a non-producer. B9 is a mouse B cell hybridoma line that requires Interleukin 6 (IL-6) for survi...

  • SPC-BM-36

    SPC-BM-36

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Derived from larvae of a silkworm (species Bombyx mori, family Bombycidae, order Lepidoptera) (Seidenspinner) https://www.creative-bioarray.com/SPC-BM-36-CSC-C6198X-item-1678.htm

  • L929/A

    L929/A

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    This Adriamycin-resistant cell line has been developed by exposure of the parent L929 murine fibroblast cell line to increasing concentrations of doxorubicin in-vitro. L929/A cells can be used in the development of novel anti-cancer treatments. Resis...